HomeCompareVRN vs JNJ

VRN vs JNJ: Dividend Comparison 2026

VRN yields 5.32% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VRN wins by $8798.63M in total portfolio value
10 years
VRN
VRN
● Live price
5.32%
Share price
$6.01
Annual div
$0.32
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8798.66M
Annual income
$8,492,265,044.67
Full VRN calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — VRN vs JNJ

📍 VRN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVRNJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VRN + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VRN pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VRN
Annual income on $10K today (after 15% tax)
$452.58/yr
After 10yr DRIP, annual income (after tax)
$7,218,425,287.97/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, VRN beats the other by $7,218,421,250.57/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VRN + JNJ for your $10,000?

VRN: 50%JNJ: 50%
100% JNJ50/50100% VRN
Portfolio after 10yr
$4399.35M
Annual income
$4,246,134,897.28/yr
Blended yield
96.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VRN
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
-0.2
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VRN buys
0
JNJ buys
0
No recent congressional trades found for VRN or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVRNJNJ
Forward yield5.32%2.14%
Annual dividend / share$0.32$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$8798.66M$30.5K
Annual income after 10y$8,492,265,044.67$4,749.88
Total dividends collected$8777.27M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: VRN vs JNJ ($10,000, DRIP)

YearVRN PortfolioVRN Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,765$1,064.89$10,594$274.49+$1.2KVRN
2$14,930$2,341.75$11,294$360.69+$3.6KVRN
3$21,530$5,554.73$12,133$476.91+$9.4KVRN
4$38,009$14,972.30$13,156$635.42+$24.9KVRN
5$90,076$49,406.23$14,432$854.61+$75.6KVRN
6$315,232$218,850.33$16,056$1,162.76+$299.2KVRN
7$1,768,870$1,431,571.67$18,175$1,604.53+$1.75MVRN
8$16,907,676$15,014,985.63$21,009$2,252.68+$16.89MVRN
9$286,353,223$268,262,009.68$24,911$3,229.73+$286.33MVRN
10$8,798,662,994$8,492,265,044.67$30,458$4,749.88+$8798.63MVRN

VRN vs JNJ: Complete Analysis 2026

VRNStock

Veren Inc. explores, develops, and produces oil and gas properties in Canada and the United States. The company focuses on crude oil, tight oil, natural gas liquids, shale gas, and natural gas reserves. Its properties are located in the provinces of Saskatchewan, Alberta, British Columbia, and Manitoba; and the states of North Dakota. The company was formerly known as Crescent Point Energy Corp. and changed its name to Veren Inc. in May 2024. Veren Inc. was incorporated in 1994 and is headquartered in Calgary, Canada.

Full VRN Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this VRN vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VRN vs SCHDVRN vs JEPIVRN vs OVRN vs KOVRN vs MAINVRN vs ABBVVRN vs MRKVRN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.